Skip to main content

Table 1 Interpretation time, results and sensitivity/specificity for each modality against the reported comparator

From: Novel three-dimensional bone ‘mapping’ software can help assess progression of osseous metastases from routine CT

Test modality

Mean interpretation time (s)

Malignant areas

Suspicious areas

Compar-ator

Sensitivity

(Exc ‘sus’)

Specificity

(Exc ‘sus’)

Sensitivity

(Inc ‘sus’)

Specificity

(Inc ‘sus’)

Bone Map

96.3

235

47

CT

70.71

73.08

69.05

58.28

CT

222.1

264

28

BS

85.63

64.71

81.56

62.89

  1. These were assessed including or excluding calls of suspicious (‘sus’) areas